OSI-774 (Tarceva) in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer
Completed · Phase 3
Conditions studied: Carcinoma, Non-small-cell Lung
In brief
The purpose of this study is to determine if OSI-774 will improve overall survival of patients with incurable stage IIIB/IV non-small cell lung cancer compared to standard of care. OSI-774 is a new type of drug under evaluation called an epidermal growth factor receptor (EGFR). OSI-774 is an investigational drug that has not yet been approved by the U.S. Food and Drug Administration (FDA).
Key facts
- Study ID
- NCT00036647
- Run by
- OSI Pharmaceuticals
- People needed
- 731
- Starts
- 2001-11-01
- Expected to finish
- 2004-01-30
- Last updated by the study team
- 2018-01-10
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- University of Washington — Seattle, Washington, United States
- Centro Medico Confidence — Buenos Aires, CP, Argentina
- Hospital Britanico — Buenos Aires, Argentina
- Hospital Interzonal de Agudos Evita — Buenos Aires, Argentina
- Instituto Alexander fleming — Buenos Aires, Argentina
- Hospital Churruca Visca — Buenos Aires, Argentina
- Instituto Oncologico Angel Roffo — Capital Federal, Argentina
- Hospital Italiano — Capital Federal, Argentina
- Canberra Hospital- Australia — Woden, Australian Capital Territory, Australia
- Prince of Wales Hospital — Randwick, New South Wales, Australia
- Newcastle Mater Misericordiae Hospital — Waratah, New South Wales, Australia
- Southern Medical Day Care Center — Wollongong, New South Wales, Australia
- Western Hospital — Footscray, Victoria, Australia
- The Royal Melbourne Hospital — Parkville, Victoria, Australia
- Sir Charles Gairdner Hospital — Nedlands, Western Australia, Australia
- Royal Adelaide Hospital — South Australia, Australia
- Peter MacCallum Cancer Institute — Victoria, Australia
- Austin & Repatriation Medical Centre — Victoria, Australia
- Instituto do Cancer do Ceara — Fortaleza, CEP, Brazil
- Instituto Nacional de Cancerologia — Rio de Janeiro, CEP, Brazil
- Nucleo de Oncologia da Bahia — Salvador, Estado de Bahia, Brazil
- Hospital Vera Cruz S/A — Belo Horizonte, MG CEP, Brazil
- Irmandade Santa Casa de Miseicordia de Porto — Porto Alegre, RS CEP, Brazil
- Hospital Sao Lucas da PUCRS — Porto Alegre, RS CEP, Brazil
- University of Chicago Medical Center — Chicago, Illinois, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.